Skip to main content

118 Ways to Improve Clinical IHC Staining

Leica Microsystems continues to make high-quality IHC more efficient with the release of eight important new antibodies in the Bond ready-to-use (RTU) format.

New antibodies:

  • Beta-Catenin (clone 17C2)
  • Cytokeratin 17 (clone E3)
  • Gastrin (polyclonal)
  • Galectin-3 (clone 9C4)
  • Ki67 (clone K2)
  • MLH1 (Mismatch Repair Protein) (clone ES05)
  • Multiple Myeloma Oncogene 1 (MUM1) (clone EAU32)
  • Tartrate-Resistance Acid Phosphatase (clone 26E5)

Leica Microsystems has selected each new product for superior performance and clinical relevance. A highlight of this release is the new K2 clone for Ki67. This new clone has shown exceptional results during development and is now recommended as the preferred Ki67 clone (the older MM1 clone will continue to be available).

Another antibody of great interest is MLH1 which helps identify individuals predisposed for hereditary non-polyposis colorectal cancer. Tartrate-Resistance Acid Phosphatase (often used in panels for identifying hairy cell leukemia) and Multiple Myeloma Oncogene 1 (useful in panels for the identification or characterization of B cell and Hodgkin’s lymphoma) will also quickly find use as diagnostic aids.

The launch of these new products expands the range of Bond ready-to-use antibodies to 118 worldwide (117 in the USA). All antibodies (including the new releases) are now available from Leica Microsystems or an authorized Bond system distributor in each region.

Renowned for being the easiest way to consistently produce diagnostic-quality IHC slides, the Bond RTU format replaces dilution, titration and mixing with a simple 4-step process:

  1. Load – place a registered container on Bond
  2. Select – choose the antibody and an optimized protocol is automatically selected
  3. Run – just press start and walk away
  4. Review – enjoy consistent, high-quality results
Image
118-ways-to-improve-clinical-ihc-staining
Registering a BOND reagent